TMCnet News
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union (London, United Kingdom - March 1st-2nd, 2018) - Research and MarketsThe "Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union" conference has been added to Research and Markets' offering. This interactive meeting will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation, which came into force in 2016. The aim of this meeting is to provide an overview of recent regulatory developments in pharmaceutical regulatory affairs in Russia and the Eurasian Union. This interactive meeting will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation, which came into force in 2016. The focus will be on practical aspects to assist in developing your regulatory strategy for product approval in these countries and the presentations will also give practical hints on the regulatory process where possible. Who should attend? This seminar will be of particular interest to:
After attending this programme you will:
Agenda: Introduction and welcome Russia - competitive landscape
Clinical trials in Russia and CIS
Marketing authorisations in Russia
CIS - regional regulatory overview
Marketing authorisations in CIS
- administrative data - translations - CPP - Dossier format - local normative documents - samples - labelling Country specific requirements for MAAs: - Ukraine, Kazakhstan, Belarus, Moldova, Georgia, Armenia, Azerbaijan, Uzbekistan, Tajikistan, Turkmenistan, Kirgizstan Regional regulatory strategy Workshop - CIS Regional Regulatory Strategy Discussion will take place throughout the two days For more information about this conference visit https://www.researchandmarkets.com/research/jh8dnr/pharmaceutical?w=4 View source version on businesswire.com: http://www.businesswire.com/news/home/20171213005930/en/ |